Back to results
US 2026/0078085 A1Published application
Ionizable lipids for nucleic acid delivery
AssigneeGlobal Life Sciences Solutions Canada ULC
InventorsNikita Jain, Anitha Thomas, Andrew William Brown
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for modifying a cell. In one embodiment, the method includes: contacting the cell with a pharmaceutical composition including a nucleic acid payload encapsulated by a lipid mix composition having a compound of Formula (I), or a pharmaceutically acceptable salt thereof; and transfecting the nucleic acid payload into the cell.
Claims20
A method for modifying a cell, the method comprising:
- contacting the cell with a pharmaceutical composition comprising a nucleic acid payload encapsulated in a lipid mix composition comprising a compound, or pharmaceutically acceptable salt thereof, of Formula I:
- wherein:
- L1 is a direct bond or C1-C5 alkylene;
- E1 is —O—, —OC(O)O—, —OC(O)-δ1, —OC(O)N(Q)-δ1, —OC(O)S-δ1, —N(Q)C(O)-δ1, —N(Q)C(O)O-δ1, —C(O)O-δ1, or —C(O)N(Q)-δ1;
- Q is H or C1-C5 alkyl;
- δ1 designates the bond linked to R1;
- R1 is selected from:
- and wherein:
- R4 and R5 are each independently C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 alkynyl;
- alternatively R4 and R5 may join to form 4-6 membered heterocyclic ring containing oxygen (O) or up to 2 nitrogen (N),
- optionally substituted with 1 or 2 substituents that are each independently C1-C6 alkyl, cyclopropyl, OH, or C1-C3 alkoxy;
- R6 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl or 2-hydroxyethyl;
- R7 is H, C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 alkynyl;
- a and c′ are each independently 1, 2, 3, 4, or 5;
- b, c and e are each independently 0, 1, or 2;
- d is 1 or 2;
- R2 is H, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, or
- L2 is a direct bond or δ2-(CR8R8′)k-δ3 wherein R8 and R8′ are each independently H, C1-C12 alkyl, C2-C12 alkenyl or C2-C12 alkynyl;
- δ2 designates the bond linked to E2, and δ3 designates the bond linked to cyclopentyl scaffold described in formula (I);
- k is 1, 2, 3, 4, or 5;
- E2 is —O—, —OC(O)O—, —OC(O)-δ4, —OC(O)N(Q)-δ4, —N(Q)C(O)-δ4, —N(Q)C(O)O-δ4, —C(O)N(Q)-δ4 or —C(O)O-δ4;
- Q is H or C1-C5 alkyl;
- where δ4 designates the bond linked to R3;
- R3 is C8-C20 alkyl, C8-C20 alkenyl, C8-C20 alkynyl,
- wherein:
- f is 0 or 1;
- g is 1 or 2;
- g′ is 1, 2, 3, 4, or 5;
- h is 0, 1, 2, 3 or 4;
- R9 is a C6-C20 chain having the formula —(CH2)i-[L4-(CH2)]j—R12, wherein:
- L4 is selected from
- i is an integer in the range 6-20;
- j is 0, 1, 2, or 3;
- R12 is H or C4-C8 alkyl;
- R9′ is H, C4-C10 alkyl, C4-C10 alkenyl, or C4-C10 alkynyl;
- R10 and R10′ are each independently C4-C10 alkyl, C4-C10 alkenyl, or C4-C10 alkynyl;
- L3 is —OC(O)-δ5, —O-δ5, or a direct bond;
- δ5 designates the bond linked to R10 and R10′;
- and
- R11=R9, or has the formula:
- and
- transfecting the nucleic acid payload into the cell.
39 more elements
Dependencies are inferred from the claim text.